Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-24 @ 10:29 PM
Ignite Modification Date: 2025-12-25 @ 8:03 PM
NCT ID: NCT01023035
Term: Leukopenia
Organ System: Blood and lymphatic system disorders
Assessment Type: None
Source Vocabulary: MedDRA 14.1
Notes: None
Study: NCT01023035
Study Brief: Boceprevir/Peginterferon/Ribavirin for Chronic Hepatitis C: Erythropoietin Use Versus Ribavirin Dose Reduction for Anemia (P06086 AM2)
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 29 18 249 View
EG001 54 21 251 View
EG002 10 8 187 View